AKT1 and cancer: Some studies have reported that resveratrol can downregulate P-gp expression by inhibiting the PI3K/Akt/mTOR signaling pathway and subsequently reduce the drug resistance of cancer cells [19, 20], suggesting that the PI3K/Akt/mTOR signaling pathway is closely related to drug resistance.